Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000919784 | SCV001065138 | likely benign | not provided | 2018-07-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029446 | SCV003687552 | uncertain significance | not specified | 2023-11-03 | criteria provided, single submitter | clinical testing | The c.2605G>A (p.A869T) alteration is located in exon 21 (coding exon 21) of the ODF2 gene. This alteration results from a G to A substitution at nucleotide position 2605, causing the alanine (A) at amino acid position 869 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |